FOLH1 and prostate carcinoma: PSMA is a type II transmembrane glycoprotein predominantly expressed on the surface of prostatic epithelial cells and is markedly upregulated in prostate cancer tissues and tumor neovasculature, while remaining minimally expressed in normal tissues such as the intestine, liver, and kidney [92].